Increased interferon-gamma (IFN-γ), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)

Clinical and Experimental Immunology

Volumn 122, Issue 3, 2000, Pages 464-470

  Csiszar A ^a,b   Nagy, Gy ^a   Gergely, P ^a   Pozsonyi, T ^a   Pocsik E ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NONE   (Hungary)

Author keywords

Cytokine; IL 10; IL 4; Interferon gamma; Systemic lupus erythematosus

Indexed keywords

BETA ACTIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4;

ADULT; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; B-LYMPHOCYTES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 0034532208     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01369.x     Document Type: Article

References (60)

1. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones
2. Systemic autoimmune disease arises from polyclonal B cell activation
3. Biology of human TH1 and TH2 cells
4. Roles of interferon-γ and interleukin-4 in murine lupus
5. Murine models of systemic lupus erythematosus
6. 1 lupus-like nephritis with monoclonal antibody to γ interferon
7. Experimental therapy of systemic lupus erythematosus: The treatment of NZB/W mice with mouse soluble interferon-γ receptor inhibits the onset of glomerulonephritis
8. Modulation of the immunoglobulin dysregulation in GVH- and SLE-like diseases by the routine IL-4 receptor (IL-4-R)
9. 1 mice
10. Cytokines and autoimunity
11. Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus
12. Decreased Th1-like and increased Th-2 like cells in systemic lupus erythematosus
13. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: Interferon-γ-secreting cells in the peripheral blood
14. Cytokine gene profile in circulating blood mononuclear cells from patients with systemic lupus erythematosus: Increased interleukin-2 but not interleukin-4 mRNA
15. Message amplification phenotyping a technique to simultaneously measure multiple mRNAs from small numbers of cells
16. Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1 beta, interleukin-10 and interferon-gamma in the lymph nodes of lupus-prone mice
17. Precultured and fresh human T-cells suppress the mitogen response of autologous lymphocytes
18. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples
19. Quantification of cytokine gene expression by competitive PCR using a colorimetric assay
20. + T cells from human immunodeficiency virus infected persons
21. Quantification of cytokine gene expression using a polymerase reaction method involving co-amplification with an internal multi-specific control
22. Standardisation of messenger RNA quantification using an RT-PCR method involving coamplification with a multi-specific internal control
23. Interleukin-10 response abnormalities in systemic lupus erythematosus
24. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis and other rheumatic diseases
25. Th1 (IL-2, interferon-gamma (IFN-γ)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)
26. Intracellular cytokine expression in whole blood preparations from normals and patients with atopic dermatitis
27. Competitor mRNA fragments for quantitation of cytokine specific transcripts in cell lysates
28. Ly-1 B (B-1) cells are the main source of B-cell derived interleukin 10
29. Cytokine gene expression in mice undergoing chronic graft-vs-host disease
30. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice
31. T cell-independent and T cell dependent B cell activation increases IFN-γR expression and renders B cells sensitive to IFN-γ-mediated inhibition
32. Biological properties of interleukin-10
33. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus
34. In viva production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus
35. IL-10 inhibits human T cell proliferation and IL-2 production
36. IL-10 inhibits cytokine production by activated macrophages
37. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production
38. Preincubation of human resting T cell clones with interleukin 10 strongly enhances their ability to produce cytokines after stimulation
39. Towards a comprehensive view of immunoglobulin class switching
40. Relationship of interleukin-4 to isotypic distribution of anti-double-stranded DNA antibodies in systemic lupus erythematosus
41. Sex hormones and pregnancy in rheumatoid arthritis and systemic lupus erythematosus
42. In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans
43. Regulation of fetal allograft survival by hormone-controlled Th1- and Th2-type cytokines
44. Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with women
45. Profile of cytokine mRNA expression in peri-implantation human endometrium
46. Differential regulation of IL-1 production in human monocytes is transcriptionally and post-transcriptionally regulated by IL-4
47. Elevated monocyte interleukin-6 production in immunosuppressed trauma patients. II. Downregulation by IL-4
48. Cytokine production by phytohemagglutinin-stimulated human blood cells: Effects of corticosteroids, T cell immunosuppressants and phosphodiesterase IV inhibitors
49. Methyl-prednisolone upregulates monocyte interleukin-10 production in stimulated whole blood
50. Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse
51. Effect of high-dose methylprednisolone administration on immune functions in multiple sclerosis patients
52. Interleukin-4 gene expression in human peripheral blood mononuclear cells
53. Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa
54. Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: Increased interleukin-4 production and associated eosinophilia
55. Influence of methylprednisolone on cytokine balance during cardiac surgery
56. Interleukin-10 regulation in normal subjects and patients with asthma
57. Serum IL-6, TNFalpha, p55srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus
58. Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis
59. Production of IL-1beta, IL-1 receptor antagonist and IL-10 by mononuclear cells from patients with SLE
60. Decreased spontaneous and lipopolysaccharide stimulated production of interleukin 8 by polymorphonuclear neutrophils of patients with active systemic lupus erythematosus